AzTrials
AzTrials

Osteoarthritis, KneeADB_01NCT07517159

Adductor Canal Block Combined With Local Infiltration Analgesia vs Local Infiltration Analgesia Alone for Postoperative Pain in Total Knee Arthroplasty

A study testing Adductor Canal block and Local Infiltration Analgesia in people with Osteoarthritis, Knee, run by Ankara University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Total knee arthroplasty (TKA) is commonly associated with significant postoperative pain, which may impair early mobilization and functional recovery. Multimodal analgesia techniques are widely used to improve postoperative pain control while minimizing opioid consumption. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Osteoarthritis, Knee
What is being tested?
Adductor Canal block and Local Infiltration Analgesia
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
61 participants
Where
1 siteTurkey (Türkiye)
Study dates
31 May 2025to 15 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients aged 18 years and older
  • Patients scheduled for elective total knee arthroplasty
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Patients who provided written informed consent

Who cannot join

  • Known allergy to local anesthetics
  • Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia
  • Infection at the injection site
  • Severe hepatic or renal dysfunction
  • Neurological disorders affecting lower extremities
  • Cognitive impairment preventing pain assessment
  • Refusal to participate
  • Body mass index (BMI) greater than 30 kg/m²

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ankara University Faculty of Medicine, Ibni Sina Hospital

    Ankara, Ankara, 06100

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of the Effect of Adductor Canal Block Combined With Local Infiltration Analgesia Versus Local Infiltration Analgesia Alone on Postoperative Pain Scores in Total Knee Arthroplasty

Total knee arthroplasty (TKA) is commonly associated with significant postoperative pain, which may impair early mobilization and functional recovery. Multimodal analgesia techniques are widely used to improve postoperative pain control while minimizing opioid consumption. Local infiltration analgesia (LIA) is a commonly used method; however, its effectiveness may be limited when used alone. The adductor canal block (ACB) provides effective analgesia while preserving quadriceps muscle strength.

This prospective randomized controlled study aims to compare the effectiveness of adductor canal block combined with local infiltration analgesia versus local infiltration analgesia alone on postoperative pain scores in patients undergoing total knee arthroplasty. The primary outcome is postoperative pain assessed using the NRS at multiple time points within the first 48 hours. Secondary outcomes include opioid consumption, functional recovery parameters and hemodynamic parameters.

The results of this study are expected to contribute to optimizing postoperative analgesia strategies in total knee arthroplasty.

Read the detailed description

Total knee arthroplasty (TKA) is frequently associated with moderate to severe postoperative pain, which can negatively affect early mobilization, rehabilitation, and patient satisfaction. Effective pain management strategies are essential for enhanced recovery protocols. Multimodal analgesia has become the standard approach, combining different techniques to improve analgesic efficacy while reducing opioid-related side effects.

Local infiltration analgesia (LIA) is widely used as part of multimodal analgesia; however, it may not always provide sufficient analgesia when used alone. The adductor canal block (ACB) has gained popularity due to its ability to provide sensory blockade of the saphenous nerve while preserving quadriceps muscle strength, thus facilitating early mobilization.

This prospective randomized controlled trial was conducted to evaluate the effect of combining ACB with LIA compared to LIA alone in patients undergoing total knee arthroplasty. Patients were randomly assigned into two groups: one group received ACB combined with LIA, while the control group received LIA alone.

Postoperative pain was assessed using the Visual Analog Scale (VAS) at 2, 6, 12, 24 and 48 hours postoperatively. Secondary outcomes included total opioid consumption and functional recovery parameters. Demographic data, operative variables, and perioperative characteristics were also recorded and analyzed.

The findings of this study aim to provide evidence regarding the efficacy of combining regional anesthesia techniques with local infiltration analgesia in improving postoperative pain control following total knee arthroplasty.

Being tested
Adductor Canal block, Local Infiltration Analgesia
Keywords
Adductor Canal Block, Local Infiltration Analgesia, Total Knee Arthroplasty, Postoperative Pain, Multimodal Analgesia, NRS, Hemodynamic
Medical subject headings
Osteoarthritis, Knee, Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Adductor Canal blockProcedure or surgery

    Ultrasound-guided adductor canal block was performed using local anesthetic to provide postoperative analgesia.

  • Local Infiltration AnalgesiaProcedure or surgery

    Local infiltration analgesia was administered intraoperatively using local anesthetic agents around the surgical site.

Study groups in NCT07517159
Study groupRoleWhat they receive
ACB+LIAExperimentalPatients in this group received an adductor canal block combined with local infiltration analgesia for postoperative pain management following total knee arthroplasty.
Receives: Procedure: Adductor Canal block; Procedure: Local Infiltration Analgesia
LIAActive comparatorPatients in this group received local infiltration analgesia alone for postoperative pain management following total knee arthroplasty.
Receives: Procedure: Local Infiltration Analgesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pain at rest (Numerating Rating Scale, NRS)

    Postoperative pain was assessed using the NRS at rest at predefined time points. Postoperative pain was assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Pain scores were recorded at rest at predefined time points.

    Measured: 2,6,12,24,48

Secondary outcomes (4)
  1. Opioid Consumption

    Total opioid consumption within the first 48 hours postoperatively.

    Measured: 0-48 hours postoperatively

  2. Knee flexion range of motion (degrees) measured with a goniometer

    Functional recovery will be assessed by measuring knee flexion range of motion (degrees) using a standard goniometer at predefined postoperative time points.

    Measured: 24 and 48 hours postoperatively

  3. Heart rate (beats per minute)

    Heart rate (beats per minute) will be recorded at baseline and at 15-minute intervals from induction of anesthesia to extubation.

    Measured: Baseline (preoperative) and every 15 minutes from induction of anesthesia to extubation

  4. Mean arterial pressure (mmHg)

    Mean arterial pressure (mmHg) will be recorded at baseline (preoperative) and at 15-minute intervals during the intraoperative period.

    Measured: Baseline (before induction of anesthesia) and every 15 minutes from induction of anesthesia to extubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2026
  2. Study start31 May 2025
  3. Primary completion15 Nov 2025
  4. Study completion15 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
61 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07517159
Sponsor's protocol ID
08-349-25
Acronym
ADB_01
Status last verified
Mar 2026
First submitted
24 Mar 2026
Last updated
8 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Adductor Canal block and Local Infiltration Analgesia in people with Osteoarthritis, Knee, run by Ankara University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pain at rest (Numerating Rating Scale, NRS) (time frame: 2,6,12,24,48). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in